139 related articles for article (PubMed ID: 36566807)
1. Cancer immunotherapeutic effect of carboxymethylated β-d-glucan coupled with iron oxide nanoparticles via reprogramming tumor-associated macrophages.
Su Y; Yang F; Wang M; Cheung PCK
Int J Biol Macromol; 2023 Feb; 228():692-705. PubMed ID: 36566807
[TBL] [Abstract][Full Text] [Related]
2. Mushroom Carboxymethylated β-d-Glucan Functions as a Macrophage-Targeting Carrier for Iron Oxide Nanoparticles and an Inducer of Proinflammatory Macrophage Polarization for Immunotherapy.
Su Y; Yang F; Chen L; Cheung PCK
J Agric Food Chem; 2022 Jun; 70(23):7110-7121. PubMed ID: 35652418
[TBL] [Abstract][Full Text] [Related]
3. Ferumoxytol-β-glucan Inhibits Melanoma Growth via Interacting with Dectin-1 to Polarize Macrophages into M1 Phenotype.
Liu X; Xu Y; Li Y; Pan Y; Zhao S; Hou Y
Int J Med Sci; 2021; 18(14):3125-3139. PubMed ID: 34400883
[No Abstract] [Full Text] [Related]
4. Bioactive iron oxide nanoparticles suppress osteoclastogenesis and ovariectomy-induced bone loss through regulating the TRAF6-p62-CYLD signaling complex.
Liu L; Jin R; Duan J; Yang L; Cai Z; Zhu W; Nie Y; He J; Xia C; Gong Q; Song B; Anderson JM; Ai H
Acta Biomater; 2020 Feb; 103():281-292. PubMed ID: 31866569
[TBL] [Abstract][Full Text] [Related]
5. Interaction of Iron Oxide Nanoparticles with Macrophages Is Influenced Distinctly by "Self" and "Non-Self" Biological Identities.
Portilla Y; Mulens-Arias V; Daviu N; Paradela A; Pérez-Yagüe S; Barber DF
ACS Appl Mater Interfaces; 2023 Aug; 15(30):35906-35926. PubMed ID: 37478159
[TBL] [Abstract][Full Text] [Related]
6. The Use of Iron Oxide Nanoparticles to Reprogram Macrophage Responses and the Immunological Tumor Microenvironment.
Mulens-Arias V; Rojas JM; Barber DF
Front Immunol; 2021; 12():693709. PubMed ID: 34177955
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for cancer: effects of iron oxide nanoparticles on polarization of tumor-associated macrophages.
Nascimento CS; Alves ÉAR; de Melo CP; Corrêa-Oliveira R; Calzavara-Silva CE
Nanomedicine (Lond); 2021 Dec; 16(29):2633-2650. PubMed ID: 34854309
[TBL] [Abstract][Full Text] [Related]
8. Targeted Imaging of CD206 Expressing Tumor-Associated M2-like Macrophages Using Mannose-Conjugated Antibiofouling Magnetic Iron Oxide Nanoparticles.
Li Y; Wu H; Ji B; Qian W; Xia S; Wang L; Xu Y; Chen J; Yang L; Mao H
ACS Appl Bio Mater; 2020 Jul; 3(7):4335-4347. PubMed ID: 34841220
[TBL] [Abstract][Full Text] [Related]
9. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth.
Cao M; Yan H; Han X; Weng L; Wei Q; Sun X; Lu W; Wei Q; Ye J; Cai X; Hu C; Yin X; Cao P
J Immunother Cancer; 2019 Nov; 7(1):326. PubMed ID: 31775862
[TBL] [Abstract][Full Text] [Related]
10. Iron oxide nanoparticles size-dependently activate mouse primary macrophages via oxidative stress and endoplasmic reticulum stress.
Ying H; Ruan Y; Zeng Z; Bai Y; Xu J; Chen S
Int Immunopharmacol; 2022 Apr; 105():108533. PubMed ID: 35063754
[TBL] [Abstract][Full Text] [Related]
11. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
13. Curdlan (
Liu J; Tang J; Li X; Yan Q; Ma J; Jiang Z
Molecules; 2019 Nov; 24(23):. PubMed ID: 31766621
[TBL] [Abstract][Full Text] [Related]
14. In situ Engineering of Tumor-Associated Macrophages via a Nanodrug-Delivering-Drug (β-Elemene@Stanene) Strategy for Enhanced Cancer Chemo-Immunotherapy.
Chen W; Li Y; Liu C; Kang Y; Qin D; Chen S; Zhou J; Liu HJ; Ferdows BE; Patel DN; Huang X; Koo S; Kong N; Ji X; Cao Y; Tao W; Xie T
Angew Chem Int Ed Engl; 2023 Oct; 62(41):e202308413. PubMed ID: 37380606
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
16. Development of Toll-like Receptor Agonist-Loaded Nanoparticles as Precision Immunotherapy for Reprogramming Tumor-Associated Macrophages.
Zhang Y; Chen Y; Li J; Zhu X; Liu Y; Wang X; Wang H; Yao Y; Gao Y; Chen Z
ACS Appl Mater Interfaces; 2021 Jun; 13(21):24442-24452. PubMed ID: 34008947
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Effect of Repolarization of M2 to M1 Macrophages Induced by Iron Oxide Nanoparticles Combined with Lactate Oxidase.
Liao ZX; Ou DL; Hsieh MJ; Hsieh CC
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948143
[TBL] [Abstract][Full Text] [Related]
18. Beta-1,6 glucan converts tumor-associated macrophages into an M1-like phenotype.
Cheng H; Sun L; Shen D; Ren A; Ma F; Tai G; Fan L; Zhou Y
Carbohydr Polym; 2020 Nov; 247():116715. PubMed ID: 32829842
[TBL] [Abstract][Full Text] [Related]
19. Multi-Modal Visualization of Uptake and Distribution of Iron Oxide Nanoparticles in Macrophages, Cancer Cells, and Xenograft Models.
Liu Q; Huang J; Feng Q; Zhang T; Chen X; Li X; Liu X; Li H; Zhong Z; Xiao K
J Biomed Nanotechnol; 2019 Aug; 15(8):1801-1811. PubMed ID: 31219008
[TBL] [Abstract][Full Text] [Related]
20. Iron oxide nanoparticles served as the primary carrier to increase drug loading in macrophages.
Zhao K; Ruan L; Liu X; Wu L; Cao J; Shen S
Biomed Mater; 2022 Dec; 18(1):. PubMed ID: 36541487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
